News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
Disruptive appoints Ash Spiegelberg as Chief Strategy Officer
The AI health company names a new CSO in a standard executive appointment with no disclosed strategic details.
Halozyme licenses subcutaneous oncology tech to GSK
The drug delivery company will develop injectable formulations of GSK's cancer treatments using its enzyme platform technology.
Hyperscale Data explores sale as market cap trails book value
The data center operator is reviewing strategic options after its balance sheet value exceeded its public market valuation.
Genpact and Google Cloud expand CFO automation alliance
IT services firm Genpact deepens its Google Cloud partnership to deploy AI agents in finance operations, though specific capabilities remain undefined.
EQT sole bidder for OmniActive after rival exit
Swedish PE firm EQT remains the only contender for the $700M nutraceuticals exporter after Temasek-Novo Holdings withdrew their bid.
Pennsylvania sues Character.ai for chatbot impersonating doctor
State alleges AI chatbot provided medical advice using fake license number, marking second regulatory lawsuit against the platform.
AI scribe cuts urgent care documentation time 40% across 400k visits
Experity Health reports clinics save 155 minutes daily on notes while seeing three more patients per day, generating up to $300k additional annual revenue.
HIMSS announces CXO summit and European conference dates
Healthcare IT conference organizer sets May 2026 Copenhagen event and June Boston AI forum with clinical focus.
Amazon adds Ozempic pills to prescription vending machines
The pharmacy kiosks expand beyond Wegovy to include the second major GLP-1 drug in same-day dispensing format.
Astellas stem cell eye therapy shows mixed early results
Phase 1 data shows promise at low doses but safety questions emerge at higher doses in age-related eye disease trial.
Daiichi Sankyo loses $950M on scrapped ADC manufacturing plans
Japanese pharma company overpromised demand to third-party manufacturers and now abandons in-house antibody-drug conjugate capacity plans.
Trump plans to fire FDA Commissioner Makary per reports
Multiple outlets report the administration intends to remove Makary from his FDA role, though plans remain fluid.